Tylenol use drops among some pregnant women after Trump’s unproven autism claim
Last year, President Donald Trump told pregnant women not to take Tylenol as he promoted unproven ties between…
Does exercise really work for osteoarthritis?
Osteoarthritis is a common degenerative joint disease that causes pain, stiffness and swelling, and reduces your range of…
Sucrose reduces pain in newborns during hospital needle procedures
A new Cochrane review has found that sucrose can help with pain relief in newborn babies during common…
Warning to anyone who takes common painkiller as shortage until June
Warning to anyone who takes common painkiller as shortage to last until June (Image: Getty) Concern is growing…
Electroacupuncture relieves pain-induced anxiety through prefrontal neural circuits
Neuropathic pain, caused by injury or disease of the somatosensory nervous system, is a major clinical challenge and…
Preoperative factors predict persistent opioid use after surgery
For many Americans, a routine surgical procedure serves as their first introduction to opioid pain medication. While most…
How scientists are using virtual reality to treat chronic pain
VR and video-based approaches are still being studied, but their relatively low cost–especially with newer VR devices–and ease…
Long-term NSAID use can often lead to stomach damage
Dear Dr. Roach: I am a woman in my 80s. Is it safe to take 400 mg of…
SN101 iPSC-derived therapy relieves chronic pain and preserves joints
SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on a novel approach…
Mamdani, Louvre among most mispronounced words of 2025
DALLAS (AP) — From the election of Zohran Mamdani to the intrigue surrounding the jewel heist at the…
New NIH grants fuel research in oral cancer treatment and pain relief
Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University…
Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a…